$IBO Market AnalysisUniversal Ibogaine Inc. is a Canadian Life science company trading at TSX-V with the ticker symbol $IBO currently sits at $0.05 with volume around 8K.
Smallcap
$IBO Stock StatementUniversal Ibogaine Inc. is an expanding Canadian-holding company with an average volume of $145K+ in the last 3 months. The average volume of the company in the last 10 days is $112K with $190.74M share outstanding. The stock price when the market opened was $0.05
$IBO Upper and Lower Price in the Last 52 WeeksUniversal Ibogaine Inc. holds a significant position over the TSX-V market with its greater difference between the lower and higher ranges of trading, which is $0.0400-$0.2500 in the last 52 weeks.
$HEM volume increases
Hemostemix Inc. is a biotechnology company listed on TSX-V with ticker symbol $HEM has shown growth in its volume. Today the volume is 21.30K.
Universal Ibogaine Market SummaryUniversal Ibogaine Inc. holds a significant position over the TSX-V market with its greater difference between the lower and higher ranges of trading, which is $0.04-$0.25 in the last 52 weeks.
Dr. Sola's administration over 3700 Ibogaine Detox
Universal Ibogaine Co-Founder Dr Alberto Sola has administered over 3700 ibogaine detox treatments, more than any other doctor in the world.
$HEM announced incorporation of an entirely owned subsidiary
The business is happy to announce that PreCerv Inc. ("PreCerv") has been incorporated as a completely owned subsidiary. A worldwide field of use licence for NCP-01 and its autologous stem cell technology will be acquired by PreCerv from Hemostemix.
$IBO CO-Founder with wide ranging work-experienceDr. Sola, a co-founder of Universal Ibogaine and a member of its Board of Directors, has effectively administered over 3,700 ibogaine treatments, more than any other doctor in the world, at an independent clinic in Cancun, Mexico, where he is a partner.
CEO highlights on the sheer extent of the research to reality ev"The significance of this occasion cannot be emphasized," said CEO Nick Karos. This is the first gathering of academic researchers, real-world technicians, and government policymakers of its sort. This event will raise awareness of ibogaine's great potential at the highest levels."
Universal Ibogaine Inc. CEO’s ecstatic to work with Blue Digital
"We are happy to have access to Blue Digital's distribution channels, as their range across borders will broaden awareness of our business to new audiences," said Nick Karos, UI's Chief Executive Officer. Because addiction knows no bounds, the remedy we seek must be global in scope." As Blue Digital Media professional radar.
$HMTXF going up in flash on the OTC
$HMTXF today marked quite an impressive opening in the otc market and is currently trading with a steady pace at $0.1960 with a notable spike
Hemostemix hires new financial advisor to the family
Mr. Rick Groome who has effectively settled 2 securities firm, helping many successful biotechnology companies in providing funds over the last three decades has joined hemostemix as a special financial advisor.
$IBO stock analysis
Universal Ibogaine Inc. is an expanding Canadian-holding company with an average volume of 138 K+ in the last 50 days . The average volume of the company in the last 10 days is $88.98K with $190.74M share outstanding. The stock price when the market opened was $0.05
$IBO’S CEO comments on the H.C Wainwright
"H.C. Wainwright is a leader in the field and may be a significant strategic partner in our ongoing corporate finance roadmap," said Nick Karos, CEO of Universal Ibogaine. Another crucial step in raising awareness of our brand and service is the chance to share our story with this audience.
$IBOGF higher day rangeUniversal Ibogaine Inc. a life science company listed on OTC with the ticker symbol $IBOGF has been seen with a higher day range difference. The day range is $0.0367-$0.0385.
$HEM recoups legal guardianship of its lost intellectual The company has legally retrieved all intellectual data related to stage 2 clinical trial data, along with all previous data from Hemostemix Israel and the randomized table needed to evaluate ACP-01 clinical trial data in North America and South Africa.
Universal Ibogaine Inc. (UI) (TSXV: IBO) (OTC: IBOGF) hottest Universal Ibogaine Inc. (UI) (TSXV: IBO) (OTC: IBOGF) hottest stock making heavy profit.
Click below link to know more
“An investor without investment ideas is like a traveler without so keep Update your ideas with the new addition of $IBO
Update your watch list with the new addition of $IBO Stocks veered from bearish to bullish day by day & leaving investors amazed in the Tsx_v market
The Universal Ibogaine MissionUniversal Ibogaine is working with Health Canada to undertake a planned clinical trial in Canada to demonstrate the safety and efficacy of the Ibogaine treatment protocol for opioid use disorder.
$PQE moving ahead fiercely with an unstoppable forceThe stock today observed a brief rise in the value per share since its previous close, and the shares are actively being traded on TSX-V at $.24 per unit
$PQE Security Data BriefingThe company has maintained sturdy shares listed and issued for publicly traded activities with a valuation of 713.77 million+ viewed as a share outstanding, recorded over TSX-Venture
